-The Telegraph Reclaimed from Maoists, the natural reserves of Saranda are up against unscrupulous adversaries. At least four mining firms have been extracting iron ore and manganese against their sanctioned capacities in this West Singhbhum region since 2008 right under the nose of the mines department and Jharkhand State Pollution Control Board (JSPCB). The startling fact came to light this January after the two laggard state offices replied to separate RTI petitions filed...
More »SEARCH RESULT
Total Matching Records found : 1124
Wal-Mart in bribe scandal
-The Telegraph The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...
More »Right to Education is the wrong thing for the right reason
-The Economic Times At the peak of Anna Hazare fever last year, anybody disagreeing with his message or prescription was branded pro-corruption. Over the last few weeks, anybody expressing disappointment at the Supreme Court upholding the Right to Education (RTE) Act is being branded anti-poor or elitist. This is unfair and unnecessary: dissent is not treason. The supporters of Anna and RTE have similar traits: impatient, intellectually certain and more interested in...
More »A big step forward-CP Chandrasekhar
That this is the first time a compulsory licence has been granted in India is in itself important. INDIA'S long struggle to ensure access to affordable medicines for its people recently took a positive and interesting turn. In early March, just before he demitted office, Controller General of Patents P.H. Kurian passed an order on an application filed by Natco Pharma, headquartered in Hyderabad, requesting a licence to produce an anti-cancer...
More »A welcome first -TK Rajalakshmi
Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...
More »
